LGBT Cancer Project

Nasopharyngeal Cancer Clinical Trials

A listing of Nasopharyngeal Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

A clinical trial to evaluate treatments using INCB062079 for patients

California

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

La Jolla California 92093

A clinical trial seeking patients for a research study for the treatment of Nasopharyngeal Cancer

UPDATED

San Francisco California 94143

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

Massachusetts

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

Texas

UPDATED

Dallas Texas 75204

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

Australia

Malvern Victoria 3144

A clinical trial seeking patients for a research study of Genolimzumab injection

Melbourne Victoria 3004

A clinical trial seeking patients for a research study of Genolimzumab injection

Nedlands Western Australia 6009

A clinical trial seeking patients for a research study of Genolimzumab injection

Malaysia

UPDATED

Johor Bahru

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Kuala Lumpur

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Kuala Lumpur

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Kuala Lumpur

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Kuala Lumpur

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Penang

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Penang

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

Singapore

UPDATED

Singapore

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Singapore

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

Taiwan

UPDATED

Changhua

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Taichung

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Taichung

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Taipei

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Taipei

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

Thailand

UPDATED

Bangkok

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Bangkok

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Chiang Mai

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Khon Kaen

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Lopburi

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Ubon Ratchathani

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced

UPDATED

Udon Thani

Patients are needed to participate in a clinical research study evaluating autologous EBV specific Cytotoxic T Lymphocytes and combination IV gemcitabine and IV carboplatin (AUC2) for the treatment of Nasopharyngeal Cancer, Advanced